top of page

Retired U.S. Army Colonel Robert J. O'Connell, MD, Joins Pavaka Wound Care as Chief Medical Officer and Director of Military Affairs

Writer: Brent Toto
Brent Toto
Jan 1
2 min read

Updated: 7 days ago

COLUMBUS, Ohio — January 1, 2026 — Pavaka Wound Care has appointed Robert J. O'Connell, MD, FACP, FIDSA, a retired U.S. Army colonel and infectious disease physician, as Chief Medical Officer and Director of Military Affairs, effective January 1, 2026.


Dr. O'Connell brings more than 25 years of leadership as a military infectious disease clinician, product developer, researcher and leader. He served as a battlefield physician in Iraq and led military research organizations in Thailand and the United States. Most recently, he was Director of the Infectious Disease Clinical Research Program (IDCRP) at the Uniformed Services University of the Health Sciences.


At Pavaka, Dr. O'Connell will lead the company's clinical strategy and its engagement with the military health community. He will help shape how the company's investigational electroceutical dressing is evaluated and how it could fit into care for service members.


Infections in traumatic and chronic wounds, including those caused by multidrug-resistant organisms, are a long-standing concern in military medicine. Dr. O'Connell's career spans both sides of the problem: as a clinician caring for service members and as a research leader running clinical programs.


Pavaka's dressing generates a low-level electric field at the wound surface. It is built on technology exclusively licensed from The Ohio State University, and its earlier clinical evaluation was supported by the U.S. Department of Defense.


Dr. O'Connell joins CEO Brent Toto and CTO Frank Fischer on Pavaka's leadership team as the company advances regulatory planning, manufacturing and partnerships.


Dr. O'Connell's appointment strengthens Pavaka's ability to work with military medicine on the evidence, requirements and pathways that matter for products intended for service members. It complements the clinical and scientific expertise of the Ohio State and academic teams behind the technology.


His military experience spans clinical care in a combat theater and leadership of military research organizations at home and abroad.


"Rob has spent his career caring for service members and running the kind of clinical research that turns promising ideas into real-world care. Having him lead our clinical and military strategy is a defining moment for Pavaka." — Brent Toto, CEO and Co-Founder

Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.


About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Sources and further reading

Comments


bottom of page